This report aims to provide a comprehensive presentation of the global market for Genomics, with and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Genomics.

The Genomics market size considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Genomics market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Genomics manufacturers, new entrants, and industry chain related companies in this market with information for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

The global Genomics market size in 2022 is 36726.37 million US dollars, and it is expected to be 106136.62 million US dollars by 2029, with a compound annual growth rate of 16.37% expected in 2023-2029.

MARKET COMPETITIVE LANDSCAPE:
The main players in the Genomics market include Agilent Technologies, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), BGI (China), Color Health, Inc. (U.S.), and Danaher (U.S.). The share of the top 3 players in the Genomics market is XX%.

REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Genomics market, and Asia Pacific accounted for XX%.

SEGMENT OVERVIEW:
The report segments the market by Type and Application. Library Preparation accounted for XX% of Genomics market in 2022. Data Analysis share of XX%.
Government accounted for XX% of the Genomics market in 2022. Medical and Pharmaceutical facilities accounts for XX%.

Chapter Outline
Chapter 1: Introduces the product overview, research purposes, and then includes economic analysis of global regions, inflation analysis, and the impact of the Russian-Ukrainian war on the market.
Chapter 2: Analysis of the competitive environment of Genomics market participants. This mainly includes the revenue and market share of the top players, along with the players” M&A and expansion in recent years.
Chapters 3-5: Segmented the global Genomics market by type, application and region. Analyze the revenue of market segments from different perspectives.
Chapter 6: Analyzes the main companies in the Genomics industry, including their main businesses, products/services, revenue, gross margin, and SWOT Analysis.
Chapter 7: Analyzes the Genomics business cost, including industrial chain and the proportion of business cost structure.
Chapter 8: Introduces the market dynamics, the trends factors and drivers factors of the market, and the challenges and restraints faced by manufacturers in the industry.
Chapters 9-10: Provide detailed Genomics market forecast data, broken down by type, application, and region to help understand future growth trends.
Chapter 11: The main points and conclusions of the report.

Highlights-Regions

North America
United States
Canada
China
Asia Pacific (Excluding China)
Japan
Korea
Southeast Asia
India
Australia
EMEA
Europe
Germany
France
UK
Italy
Russia
Nordic
Middle East
Africa
Latin America
Brazil
Argentina
Mexico

Player list
Agilent Technologies, Inc. (U.S.)
Bio-Rad Laboratories, Inc. (U.S.)
BGI (China)
Color Health, Inc. (U.S.)
Danaher (U.S.)
Eppendorf SE (Germany)
Eurofins Scientific (Luxembourg)
F. Hoffmann-La Roche Ltd. (Switzerland)
GE Medical and Pharmaceutical (U.S.)
Illumina, Inc. (U.S.)
Myriad Genetics, Inc. (U.S.)
Oxford Nanopore Technologies plc. (U.K.)
PacBio (U.S.)
QIAGEN (Germany)
Diagnostics Incorporated (U.S.)
Thermo Fisher Scientific, Inc. (U.S.)
23andMe, Inc. (U.S.)
FOUNDATION MEDICINE, INC. (U.S.)
IntegraGen (France)
Genome Diagnostics Pvt. Ltd. (India)
Cytiva (U.S.)

Types list
Library Preparation
Data Analysis
Imaging

Application list
Government
Medical and Pharmaceutical facilities
Hospitals and Clinics
Diagnostics Centers,
Academic Institutes
Clinical Research
Biotechnology
Pharmaceutical Companies
Others

Table of Content

1 Genomics Market Introduction and Overview
1.1 Genomics Definition
1.2 Research Purposes
1.3 Currency Rate
1.4 Report Timeline
1.5 Economic Analysis of Global Regions
1.6 Inflation Analysis
1.7 The Impact of the Russian-Ukrainian War on the Market
2 Market Competition by Manufacturers
2.1 Global Genomics Revenue and Market Share by Manufacturer
2.2 Manufacturers Genomics Production Sites, Area Served, Product Types
2.3 Genomics Market Competitive Situation and Trends
2.3.1 Genomics Market Concentration Rate
2.3.2 Global Top 5 and Top 10 Players Market Share by Revenue in 2023
2.3.3 Mergers & Acquisitions, Expansion
3 Global Genomics Historical Market Analysis by Type
3.1 Market Size Analysis by Types
3.1.4 Global Genomics Market Share by Type 2018 VS 2022
3.2 Global Genomics Revenue and Market Share by Type
4 Global Genomics Historical and Forecast Market Analysis by Application
4.1 Market Size Analysis by Application
4.1.4 Global Genomics Market Share by Application 2018 VS 2022
4.2 Global Genomics Revenue Market Share by Application (2018-2023)
5 Global Market Growth Trends Analysis
5.1 Global Genomics Market Size (2018-2023)
5.2 Genomics Growth Trends Analysis by Regions
5.2.1 Genomics Market Size by Regions: 2018 VS 2023 VS 2029
5.2.2 Genomics Historic Revenue Market Size by Regions (2018-2023)
5.3 North America
5.3.1 North America Genomics Revenue by Countries (2018-2023)
5.3.2 North America SWOT Analysis
5.3.3 United States
5.3.4 Canada
5.4 China
5.4.1 China SWOT Analysis
5.5 Asia Pacific (Excluding China)
5.5.1 Asia Pacific Genomics Revenue by Countries (2018-2023)
5.5.2 Asia Pacific SWOT Analysis
5.5.3 Japan
5.5.4 Korea
5.5.5 Southeast Asia
5.5.6 India
5.5.7 Australia
5.6 EMEA
5.6.1 EMEA Genomics Revenue by Countries (2018-2023)
5.6.2 EMEA SWOT Analysis
5.6.3 Europe
5.6.4 Middle East
5.6.5 Africa
5.7 Latin America
5.7.1 Latin America Genomics Revenue by Countries (2018-2023)
5.7.2 Latin America SWOT Analysis
5.7.3 Brazil
5.7.4 Argentina
5.7.5 Mexico
6 Players Profiles
6.1 Agilent Technologies, Inc. (U.S.)
6.1.1 Agilent Technologies, Inc. (U.S.) Company Profile
6.1.2 Genomics Product Overview
6.1.3 Agilent Technologies, Inc. (U.S.) Genomics Market Performance (2018-2023)
6.1.4 Agilent Technologies, Inc. (U.S.) Business Overview
6.1.5 SWOT Analysis
6.2 Bio-Rad Laboratories, Inc. (U.S.)
6.2.1 Bio-Rad Laboratories, Inc. (U.S.) Company Profile
6.2.2 Genomics Product Overview
6.2.3 Bio-Rad Laboratories, Inc. (U.S.) Genomics Market Performance (2018-2023)
6.2.4 Bio-Rad Laboratories, Inc. (U.S.) Business Overview
6.2.5 SWOT Analysis
6.3 BGI (China)
6.3.1 BGI (China) Company Profile
6.3.2 Genomics Product Overview
6.3.3 BGI (China) Genomics Market Performance (2018-2023)
6.3.4 BGI (China) Business Overview
6.3.5 SWOT Analysis
6.4 Color Health, Inc. (U.S.)
6.4.1 Color Health, Inc. (U.S.) Company Profile
6.4.2 Genomics Product Overview
6.4.3 Color Health, Inc. (U.S.) Genomics Market Performance (2018-2023)
6.4.4 Color Health, Inc. (U.S.) Business Overview
6.4.5 SWOT Analysis
6.5 Danaher (U.S.)
6.5.1 Danaher (U.S.) Company Profile
6.5.2 Genomics Product Overview
6.5.3 Danaher (U.S.) Genomics Market Performance (2018-2023)
6.5.4 Danaher (U.S.) Business Overview
6.5.5 SWOT Analysis
6.6 Eppendorf SE (Germany)
6.6.1 Eppendorf SE (Germany) Company Profile
6.6.2 Genomics Product Overview
6.6.3 Eppendorf SE (Germany) Genomics Market Performance (2018-2023)
6.6.4 Eppendorf SE (Germany) Business Overview
6.6.5 SWOT Analysis
6.7 Eurofins Scientific (Luxembourg)
6.7.1 Eurofins Scientific (Luxembourg) Company Profile
6.7.2 Genomics Product Overview
6.7.3 Eurofins Scientific (Luxembourg) Genomics Market Performance (2018-2023)
6.7.4 Eurofins Scientific (Luxembourg) Business Overview
6.7.5 SWOT Analysis
6.8 F. Hoffmann-La Roche Ltd. (Switzerland)
6.8.1 F. Hoffmann-La Roche Ltd. (Switzerland) Company Profile
6.8.2 Genomics Product Overview
6.8.3 F. Hoffmann-La Roche Ltd. (Switzerland) Genomics Market Performance (2018-2023)
6.8.4 F. Hoffmann-La Roche Ltd. (Switzerland) Business Overview
6.8.5 SWOT Analysis
6.9 GE Medical and Pharmaceutical (U.S.)
6.9.1 GE Medical and Pharmaceutical (U.S.) Company Profile
6.9.2 Genomics Product Overview
6.9.3 GE Medical and Pharmaceutical (U.S.) Genomics Market Performance (2018-2023)
6.9.4 GE Medical and Pharmaceutical (U.S.) Business Overview
6.9.5 SWOT Analysis
6.10 Illumina, Inc. (U.S.)
6.10.1 Illumina, Inc. (U.S.) Company Profile
6.10.2 Genomics Product Overview
6.10.3 Illumina, Inc. (U.S.) Genomics Market Performance (2018-2023)
6.10.4 Illumina, Inc. (U.S.) Business Overview
6.10.5 SWOT Analysis
6.11 Myriad Genetics, Inc. (U.S.)
6.11.1 Myriad Genetics, Inc. (U.S.) Company Profile
6.11.2 Genomics Product Overview
6.11.3 Myriad Genetics, Inc. (U.S.) Genomics Market Performance (2018-2023)
6.11.4 Myriad Genetics, Inc. (U.S.) Business Overview
6.11.5 SWOT Analysis
6.12 Oxford Nanopore Technologies plc. (U.K.)
6.12.1 Oxford Nanopore Technologies plc. (U.K.) Company Profile
6.12.2 Genomics Product Overview
6.12.3 Oxford Nanopore Technologies plc. (U.K.) Genomics Market Performance (2018-2023)
6.12.4 Oxford Nanopore Technologies plc. (U.K.) Business Overview
6.12.5 SWOT Analysis
6.13 PacBio (U.S.)
6.13.1 PacBio (U.S.) Company Profile
6.13.2 Genomics Product Overview
6.13.3 PacBio (U.S.) Genomics Market Performance (2018-2023)
6.13.4 PacBio (U.S.) Business Overview
6.13.5 SWOT Analysis
6.14 QIAGEN (Germany)
6.14.1 QIAGEN (Germany) Company Profile
6.14.2 Genomics Product Overview
6.14.3 QIAGEN (Germany) Genomics Market Performance (2018-2023)
6.14.4 QIAGEN (Germany) Business Overview
6.14.5 SWOT Analysis
6.15 Diagnostics Incorporated (U.S.)
6.15.1 Diagnostics Incorporated (U.S.) Company Profile
6.15.2 Genomics Product Overview
6.15.3 Diagnostics Incorporated (U.S.) Genomics Market Performance (2018-2023)
6.15.4 Diagnostics Incorporated (U.S.) Business Overview
6.15.5 SWOT Analysis
6.16 Thermo Fisher Scientific, Inc. (U.S.)
6.16.1 Thermo Fisher Scientific, Inc. (U.S.) Company Profile
6.16.2 Genomics Product Overview
6.16.3 Thermo Fisher Scientific, Inc. (U.S.) Genomics Market Performance (2018-2023)
6.16.4 Thermo Fisher Scientific, Inc. (U.S.) Business Overview
6.16.5 SWOT Analysis
6.17 23andMe, Inc. (U.S.)
6.17.1 23andMe, Inc. (U.S.) Company Profile
6.17.2 Genomics Product Overview
6.17.3 23andMe, Inc. (U.S.) Genomics Market Performance (2018-2023)
6.17.4 23andMe, Inc. (U.S.) Business Overview
6.17.5 SWOT Analysis
6.18 FOUNDATION MEDICINE, INC. (U.S.)
6.18.1 FOUNDATION MEDICINE, INC. (U.S.) Company Profile
6.18.2 Genomics Product Overview
6.18.3 FOUNDATION MEDICINE, INC. (U.S.) Genomics Market Performance (2018-2023)
6.18.4 FOUNDATION MEDICINE, INC. (U.S.) Business Overview
6.18.5 SWOT Analysis
6.19 IntegraGen (France)
6.19.1 IntegraGen (France) Company Profile
6.19.2 Genomics Product Overview
6.19.3 IntegraGen (France) Genomics Market Performance (2018-2023)
6.19.4 IntegraGen (France) Business Overview
6.19.5 SWOT Analysis
6.20 Genome Diagnostics Pvt. Ltd. (India)
6.20.1 Genome Diagnostics Pvt. Ltd. (India) Company Profile
6.20.2 Genomics Product Overview
6.20.3 Genome Diagnostics Pvt. Ltd. (India) Genomics Market Performance (2018-2023)
6.20.4 Genome Diagnostics Pvt. Ltd. (India) Business Overview
6.20.5 SWOT Analysis
6.21 Cytiva (U.S.)
6.21.1 Cytiva (U.S.) Company Profile
6.21.2 Genomics Product Overview
6.21.3 Cytiva (U.S.) Genomics Market Performance (2018-2023)
6.21.4 Cytiva (U.S.) Business Overview
6.21.5 SWOT Analysis
7 Genomics Business Cost Analysis
7.1 Labor Cost Analysis
7.2 Proportion of Manufacturing Cost Structure
7.3 Genomics Industrial Chain Analysis
8 Genomics Industry Dynamic Analysis
8.1 Genomics Market Trends Analysis
8.2 Genomics Market Drivers Analysis
8.3 Genomics Market Challenges Analysis
8.4 Genomics Market Restraints Analysis
9 Global Genomics Forecast Market Analysis by Type & Application
9.1 Global Genomics Revenue Market Forecast by Type (2023-2029)
9.2 Genomics Revenue Market Forecast by Application (2023-2029)
10 Global Genomics Forecast Market Analysis by Region
10.1 Genomics Revenue Market Forecast by Region (2023-2029)
10.2 North America Genomics Forecast Market Analysis
10.3 EMEA Genomics Forecast Market Analysis
10.4 China Genomics Forecast Market Analysis
10.5 Asia-Pacific Genomics Forecast Market Analysis
10.6 Latin America Genomics Forecast Market Analysis
11 Research Findings and Conclusion

List of Tables and Figures

Figure Genomics Picture
Table Product Definition of Genomics
Table Economic Analysis of Global Regions
Table Inflation Analysis
Table The Impact of the Russian-Ukrainian War on the Market
Table Global Genomics Revenue ($) by Manufacturer (2018-2023)
Table Global Genomics Revenue Market Share by Manufacturer (2018-2023)
Figure Global Genomics Revenue Market Share by Manufacturer in 2023
Table Manufacturers Genomics Production Sites, Area Served, Product Types
Table Genomics Market Concentration Rate
Figure Global Top 5 and Top 10 Players Market Share by Revenue in 2023
Table Mergers & Acquisitions, Expansion Plans
Table Global Genomics Market Size by Type (2023 VS 2029)
Figure Global Genomics Market Share by Type 2018 VS 2022
Table Global Genomics Revenue and Market Size by Type (2018-2023)
Table Global Genomics Revenue and Market Share by Type (2018-2023)
Table Global Genomics Market Size by Application (2023 VS 2029)
Figure Global Genomics Market Share by Application 2018 VS 2022
Table Global Genomics Revenue Market Size by Application (2018-2023)
Table Global Genomics Revenue Market Share by Application (2018-2023)
Figure Global Genomics Revenue Market Size (2018-2023)
Table Genomics Market Size by Regions: 2018 VS 2023 VS 2029
Table Genomics Historic Revenue Market Size by Regions (2018-2023)
Table Genomics Historic Revenue Market Share by Regions (2018-2023)
Figure North America Genomics Revenue and Growth (2018-2023)
Table North America Genomics Revenue by Countries (2018-2023)
Table North America Genomics Revenue Market Share by Countries (2018-2023)
Table North America SWOT Analysis
Figure United States Genomics Revenue and Growth (2018-2023)
Figure Canada Genomics Revenue and Growth (2018-2023)
Table China SWOT Analysis
Figure China Genomics Revenue and Growth (2018-2023)
Figure Asia Pacific Genomics Revenue and Growth (2018-2023)
Table Asia-Pacific Genomics Revenue by Countries (2018-2023)
Table Asia-Pacific Genomics Revenue Market Share by Countries (2018-2023)
Table Asia Pacific SWOT Analysis
Figure Japan Genomics Revenue and Growth (2018-2023)
Figure Korea Genomics Revenue and Growth (2018-2023)
Figure Southeast Asia Genomics Revenue and Growth (2018-2023)
Figure India Genomics Revenue and Growth (2018-2023)
Figure Australia Genomics Revenue and Growth (2018-2023)
Figure EMEA Genomics Revenue and Growth (2018-2023)
Table EMEA Genomics Revenue by Countries (2018-2023)
Table EMEA Genomics Revenue Market Share by Countries (2018-2023)
Table EMEA SWOT Analysis
Figure Europe Genomics Revenue and Growth (2018-2023)
Figure Germany Genomics Revenue and Growth (2018-2029)
Figure France Genomics Revenue and Growth (2018-2029)
Figure UK Genomics Revenue and Growth (2018-2029)
Figure Italy Genomics Revenue and Growth (2018-2029)
Figure Russia Genomics Revenue and Growth (2018-2029)
Figure Nordic Genomics Revenue and Growth (2018-2029)
Figure Middle East Genomics Revenue and Growth (2018-2023)
Figure Africa Genomics Revenue and Growth (2018-2023)
Figure Latin America Genomics Revenue and Growth (2018-2023)
Table Latin America Genomics Revenue by Countries (2018-2023)
Table Latin America Genomics Revenue Market Share by Countries (2018-2023)
Table Latin America SWOT Analysis
Figure Brazil Genomics Revenue and Growth (2018-2023)
Figure Argentina Genomics Revenue and Growth (2018-2023)
Figure Mexico Genomics Revenue and Growth (2018-2023)
Table Agilent Technologies, Inc. (U.S.) Profile
Table Product Overview
Table Agilent Technologies, Inc. (U.S.) Genomics Revenue, Gross and Gross Margin (2018-2023)
Figure Agilent Technologies, Inc. (U.S.) Revenue and Growth Rate
Figure Agilent Technologies, Inc. (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table SWOT Analysis
Table Bio-Rad Laboratories, Inc. (U.S.) Profile
Table Product Overview
Table Bio-Rad Laboratories, Inc. (U.S.) Genomics Revenue, Gross and Gross Margin (2018-2023)
Figure Bio-Rad Laboratories, Inc. (U.S.) Revenue and Growth Rate
Figure Bio-Rad Laboratories, Inc. (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table SWOT Analysis
Table BGI (China) Profile
Table Product Overview
Table BGI (China) Genomics Revenue, Gross and Gross Margin (2018-2023)
Figure BGI (China) Revenue and Growth Rate
Figure BGI (China) Revenue Market Share 2017-2022
Table Business Overview
Table SWOT Analysis
Table Color Health, Inc. (U.S.) Profile
Table Product Overview
Table Color Health, Inc. (U.S.) Genomics Revenue, Gross and Gross Margin (2018-2023)
Figure Color Health, Inc. (U.S.) Revenue and Growth Rate
Figure Color Health, Inc. (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table SWOT Analysis
Table Danaher (U.S.) Profile
Table Product Overview
Table Danaher (U.S.) Genomics Revenue, Gross and Gross Margin (2018-2023)
Figure Danaher (U.S.) Revenue and Growth Rate
Figure Danaher (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table SWOT Analysis
Table Eppendorf SE (Germany) Profile
Table Product Overview
Table Eppendorf SE (Germany) Genomics Revenue, Gross and Gross Margin (2018-2023)
Figure Eppendorf SE (Germany) Revenue and Growth Rate
Figure Eppendorf SE (Germany) Revenue Market Share 2017-2022
Table Business Overview
Table SWOT Analysis
Table Eurofins Scientific (Luxembourg) Profile
Table Product Overview
Table Eurofins Scientific (Luxembourg) Genomics Revenue, Gross and Gross Margin (2018-2023)
Figure Eurofins Scientific (Luxembourg) Revenue and Growth Rate
Figure Eurofins Scientific (Luxembourg) Revenue Market Share 2017-2022
Table Business Overview
Table SWOT Analysis
Table F. Hoffmann-La Roche Ltd. (Switzerland) Profile
Table Product Overview
Table F. Hoffmann-La Roche Ltd. (Switzerland) Genomics Revenue, Gross and Gross Margin (2018-2023)
Figure F. Hoffmann-La Roche Ltd. (Switzerland) Revenue and Growth Rate
Figure F. Hoffmann-La Roche Ltd. (Switzerland) Revenue Market Share 2017-2022
Table Business Overview
Table SWOT Analysis
Table GE Medical and Pharmaceutical (U.S.) Profile
Table Product Overview
Table GE Medical and Pharmaceutical (U.S.) Genomics Revenue, Gross and Gross Margin (2018-2023)
Figure GE Medical and Pharmaceutical (U.S.) Revenue and Growth Rate
Figure GE Medical and Pharmaceutical (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table SWOT Analysis
Table Illumina, Inc. (U.S.) Profile
Table Product Overview
Table Illumina, Inc. (U.S.) Genomics Revenue, Gross and Gross Margin (2018-2023)
Figure Illumina, Inc. (U.S.) Revenue and Growth Rate
Figure Illumina, Inc. (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table SWOT Analysis
Table Myriad Genetics, Inc. (U.S.) Profile
Table Product Overview
Table Myriad Genetics, Inc. (U.S.) Genomics Revenue, Gross and Gross Margin (2018-2023)
Figure Myriad Genetics, Inc. (U.S.) Revenue and Growth Rate
Figure Myriad Genetics, Inc. (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table SWOT Analysis
Table Oxford Nanopore Technologies plc. (U.K.) Profile
Table Product Overview
Table Oxford Nanopore Technologies plc. (U.K.) Genomics Revenue, Gross and Gross Margin (2018-2023)
Figure Oxford Nanopore Technologies plc. (U.K.) Revenue and Growth Rate
Figure Oxford Nanopore Technologies plc. (U.K.) Revenue Market Share 2017-2022
Table Business Overview
Table SWOT Analysis
Table PacBio (U.S.) Profile
Table Product Overview
Table PacBio (U.S.) Genomics Revenue, Gross and Gross Margin (2018-2023)
Figure PacBio (U.S.) Revenue and Growth Rate
Figure PacBio (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table SWOT Analysis
Table QIAGEN (Germany) Profile
Table Product Overview
Table QIAGEN (Germany) Genomics Revenue, Gross and Gross Margin (2018-2023)
Figure QIAGEN (Germany) Revenue and Growth Rate
Figure QIAGEN (Germany) Revenue Market Share 2017-2022
Table Business Overview
Table SWOT Analysis
Table Diagnostics Incorporated (U.S.) Profile
Table Product Overview
Table Diagnostics Incorporated (U.S.) Genomics Revenue, Gross and Gross Margin (2018-2023)
Figure Diagnostics Incorporated (U.S.) Revenue and Growth Rate
Figure Diagnostics Incorporated (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table SWOT Analysis
Table Thermo Fisher Scientific, Inc. (U.S.) Profile
Table Product Overview
Table Thermo Fisher Scientific, Inc. (U.S.) Genomics Revenue, Gross and Gross Margin (2018-2023)
Figure Thermo Fisher Scientific, Inc. (U.S.) Revenue and Growth Rate
Figure Thermo Fisher Scientific, Inc. (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table SWOT Analysis
Table 23andMe, Inc. (U.S.) Profile
Table Product Overview
Table 23andMe, Inc. (U.S.) Genomics Revenue, Gross and Gross Margin (2018-2023)
Figure 23andMe, Inc. (U.S.) Revenue and Growth Rate
Figure 23andMe, Inc. (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table SWOT Analysis
Table FOUNDATION MEDICINE, INC. (U.S.) Profile
Table Product Overview
Table FOUNDATION MEDICINE, INC. (U.S.) Genomics Revenue, Gross and Gross Margin (2018-2023)
Figure FOUNDATION MEDICINE, INC. (U.S.) Revenue and Growth Rate
Figure FOUNDATION MEDICINE, INC. (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table SWOT Analysis
Table IntegraGen (France) Profile
Table Product Overview
Table IntegraGen (France) Genomics Revenue, Gross and Gross Margin (2018-2023)
Figure IntegraGen (France) Revenue and Growth Rate
Figure IntegraGen (France) Revenue Market Share 2017-2022
Table Business Overview
Table SWOT Analysis
Table Genome Diagnostics Pvt. Ltd. (India) Profile
Table Product Overview
Table Genome Diagnostics Pvt. Ltd. (India) Genomics Revenue, Gross and Gross Margin (2018-2023)
Figure Genome Diagnostics Pvt. Ltd. (India) Revenue and Growth Rate
Figure Genome Diagnostics Pvt. Ltd. (India) Revenue Market Share 2017-2022
Table Business Overview
Table SWOT Analysis
Table Cytiva (U.S.) Profile
Table Product Overview
Table Cytiva (U.S.) Genomics Revenue, Gross and Gross Margin (2018-2023)
Figure Cytiva (U.S.) Revenue and Growth Rate
Figure Cytiva (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table SWOT Analysis
Table Labor Cost Analysis
Figure Proportion of Manufacturing Cost Structure
Figure Genomics Industrial Chain Analysis
Table Market Trends Analysis
Table Market Drivers Analysis
Table Market Challenges Analysis
Table Market Restraints Analysis
Table Global Genomics Revenue Market Size Forecast by Type (2023-2029)
Table Global Genomics Revenue Market Share Forecast by Type (2023-2029)
Table Global Genomics Revenue Market Size by Application (2023-2029)
Table Global Genomics Revenue Market Share by Application (2023-2029)
Table Global Genomics Revenue Market Size by Region (2023-2029)
Table Global Genomics Revenue Market Share by Region (2023-2029)
Figure North America Genomics Forecast Revenue and Growth 2023-2029
Figure EMEA Genomics Forecast Revenue and Growth 2023-2029
Figure China Genomics Forecast Revenue and Growth 2023-2029
Figure Asia-Pacific Genomics Forecast Revenue and Growth 2023-2029
Figure Latin America Genomics Forecast Revenue and Growth 2023-2029